(Q46719870)

24 December 2017

title

Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats (English)

1 reference

24 December 2017

1 reference

1

1 reference

24 December 2017

author name string

Ludger Leifeld

2

1 reference

24 December 2017

Martin Hennenberg

3

1 reference

24 December 2017

Erwin Biecker

4

1 reference

24 December 2017

Andreas Eckhardt

5

1 reference

24 December 2017

Nicolas Fischer

6

1 reference

24 December 2017

Andrea Schulze Pröbsting

7

1 reference

24 December 2017

Christoph Clemens

8

1 reference

24 December 2017

Frank Lammert

9

1 reference

24 December 2017

Tilman Sauerbruch

10

1 reference

24 December 2017

Jörg Heller

11

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

24 December 2017

published in

Hepatology

1 reference

24 December 2017

volume

47

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

1264-1276

1 reference

24 December 2017

Urotensin II and renal function in the rat

cites work

1 reference

Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure.

21 January 2018

1 reference

Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta.

21 January 2018

1 reference

Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase

21 January 2018

1 reference

Circulatory changes in chronic liver disease

21 January 2018

1 reference

7 January 2021

Liver microvascular architecture: an insight into the pathophysiology of portal hypertension

1 reference

7 January 2021

Complications of cirrhosis. I. Portal hypertension.

1 reference

7 January 2021

Hyperdynamic circulation in cirrhosis: a role for nitric oxide?

1 reference

7 January 2021

Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance

1 reference

7 January 2021

Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats

1 reference

7 January 2021

Vascular dysfunction in human and rat cirrhosis: role of receptor-desensitizing and calcium-sensitizing proteins

1 reference

7 January 2021

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

1 reference

7 January 2021

Human urotensin-II is a potent vasoactive peptide: pharmacological characterization in the rat, mouse, dog and primate

1 reference

7 January 2021

Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey

1 reference

7 January 2021

Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats

1 reference

7 January 2021

Regional heterogeneity in the haemodynamic responses to urotensin II infusion in relation to UT receptor localisation

1 reference

7 January 2021

Human urotensin II as a link between hypertension and coronary artery disease

1 reference

7 January 2021

The role of urotensin II in cardiovascular and renal physiology and diseases

1 reference

7 January 2021

Urotensin II: ancient hormone with new functions in vertebrate body fluid regulation

1 reference

7 January 2021

Urotensin II is an autocrine/paracrine growth factor for the porcine renal epithelial cell line, LLCPK1.

1 reference

7 January 2021

Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension

1 reference

7 January 2021

Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System

1 reference

7 January 2021

Pharmacodynamics and pharmacokinetics of the urotensin II receptor antagonist palosuran in macroalbuminuric, diabetic patients

1 reference

7 January 2021

The urotensin-II receptor antagonist palosuran improves pancreatic and renal function in diabetic rats

1 reference

7 January 2021

Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats

1 reference

7 January 2021

Enzyme immunoassay techniques an overview

1 reference

7 January 2021

Amplification systems in immunoenzymatic techniques

1 reference

7 January 2021

Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase

1 reference

7 January 2021

Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction

1 reference

7 January 2021

Phosphorylation of blood vessel vasodilator-stimulated phosphoprotein at serine 239 as a functional biochemical marker of endothelial nitric oxide/cyclic GMP signaling

1 reference

7 January 2021

Association of the myosin-binding subunit of myosin phosphatase and moesin: dual regulation of moesin phosphorylation by Rho-associated kinase and myosin phosphatase

1 reference

7 January 2021

Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis

1 reference

7 January 2021

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

1 reference

7 January 2021

Anesthetic influences on regional hemodynamics in normal and hemorrhaged rats.

1 reference

7 January 2021

Characterisation of portal hypertension models by microspheres in anaesthetised rats: a comparison of liver flow

1 reference

7 January 2021

Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase

1 reference

7 January 2021

Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries

1 reference

7 January 2021

Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase

1 reference

7 January 2021

Rho GTPases, statins, and nitric oxide

1 reference

7 January 2021

Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis

1 reference

7 January 2021

Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.22170

1 reference

24 December 2017

release_lkucrdaqozhmrowgvuekmrelxm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lkucrdaqozhmrowgvuekmrelxm

24 November 2022

mapped directly with Wikidata item

1 reference

24 December 2017